GAMOPHEN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Gamophen, and when can generic versions of Gamophen launch?
Gamophen is a drug marketed by Arbrook and is included in one NDA.
The generic ingredient in GAMOPHEN is hexachlorophene. There are seven drug master file entries for this compound. Additional details are available on the hexachlorophene profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for GAMOPHEN?
- What are the global sales for GAMOPHEN?
- What is Average Wholesale Price for GAMOPHEN?
Summary for GAMOPHEN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 80 |
| Patent Applications: | 3,334 |
| DailyMed Link: | GAMOPHEN at DailyMed |
US Patents and Regulatory Information for GAMOPHEN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Arbrook | GAMOPHEN | hexachlorophene | SOAP;TOPICAL | 006270-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
